Laurus Labs has informed that a meeting of the Board of Directors of the Company will be held on February 09, 2017, to consider and approve the Unaudited Financial Results of the Company for the Quarter and 9 months period ended December 31, 2016. Further, the Company’s trading window for dealing in securities by the Directors and Designated Persons shall be closed from February 03, 2017 to February 11, 2017.
The above information is a part of company’s filings submitted to BSE.